Viking Therapeutics (VKTX)

8.38 -0.10 (1.18%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/8/19 *Est.)

Latest Headlines

Viking Therapeutics (VKTX) call put ratio 7 calls to 1 put with focus on May 9 and 10 calls May 16, 2019 3:33 PM - StreetInsider Viking Therapeutic (VKTX) PT Raised to $41 at Raymond James May 3, 2019 7:51 AM - StreetInsider Form 10-Q Viking Therapeutics, For: Mar 31 May 2, 2019 5:12 PM - SEC Filing Viking Therapeutics (VKTX) Tops Q1 EPS by 2c May 2, 2019 4:13 PM - StreetInsider Form 8-K Viking Therapeutics, For: May 02 May 2, 2019 4:09 PM - SEC Filing Viking Therapeutics Reports First Quarter 2019 Financial Results and Provides Corporate Update May 2, 2019 4:06 PM - PR NewsWire Viking Therapeutics to Participate in Upcoming Investor Conferences April 30, 2019 7:30 AM - PR NewsWire Viking Therapeutics to Report Financial Results for First Quarter 2019 on May 2, 2019 April 25, 2019 7:30 AM - PR NewsWire Viking Therapeutic (VKTX) KOL Dinner Thoughts - Raymond James April 15, 2019 8:52 AM - StreetInsider Pre-Open Stock Movers 04/11: (FRSH) (VKTX) (LEDS) Higher; (ICPT) (BBBY) (TSLA) Lower (more...) April 11, 2019 9:22 AM - StreetInsider Raymond James Reiterates Strong Buy Rating on Viking Therapeutic (VKTX) April 11, 2019 8:18 AM - StreetInsider Viking Therapeutics (VKTX) Presents New Data from Phase 2 Study of VK2809 in Patients with NAFLD and Elevated LDL-Cholesterol at EASL April 11, 2019 7:03 AM - StreetInsider Viking Therapeutics Presents New Data from Phase 2 Study of VK2809 in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD) and Elevated LDL-Cholesterol at The International Liver Congress™ 2019 April 11, 2019 7:02 AM - PR NewsWire Form SC 13G/A Viking Therapeutics, Filed by: STATE STREET CORP April 10, 2019 1:51 PM - SEC Filing Form DEFA14A Viking Therapeutics, April 5, 2019 4:44 PM - SEC Filing Form DEF 14A Viking Therapeutics, For: May 23 April 5, 2019 4:26 PM - SEC Filing Viking (VKTX) to Present New Data from Phase 2 Study of VK2809 in Patients with NAFLD and Elevated LDL-Cholesterol April 4, 2019 7:32 AM - StreetInsider Viking Therapeutics to Present New Data from Phase 2 Study of VK2809 in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD) and Elevated LDL-Cholesterol at The International Liver Congress™ 2019 April 4, 2019 7:30 AM - PR NewsWire Pre-Open Stock Movers 03/29: (BOXL) (PRGS) (CELG) Higher; (SGH) (RH) (CHMA) Lower (more...) March 29, 2019 9:27 AM - StreetInsider SVB Leerink Upgrades Viking Therapeutic (VKTX) to Outperform March 29, 2019 6:11 AM - StreetInsider Viking Therapeutics to Participate in Upcoming Investor Conferences March 28, 2019 7:30 AM - PR NewsWire Maxim Group Reiterates Buy Rating, $20 PT on Viking Therapeutic (VKTX) March 27, 2019 1:27 PM - StreetInsider Pre-Open Stock Movers 03/27: (SCVL) (WCG) (LEN) Higher; (CBL) (HOME) (CNC) Lower (more...) March 27, 2019 9:28 AM - StreetInsider Viking Therapeutics (VKTX) Strength Said tied to Release of Abstract on VK2809 March 27, 2019 8:52 AM - StreetInsider Viking Therapeutic (VKTX) PT Lowered to $20 at Maxim Group, Remains Bullish March 14, 2019 7:35 AM - StreetInsider Form S-8 Viking Therapeutics, March 13, 2019 6:56 PM - SEC Filing Form 10-K Viking Therapeutics, For: Dec 31 March 13, 2019 5:03 PM - SEC Filing Form 8-K Viking Therapeutics, For: Mar 13 March 13, 2019 4:14 PM - SEC Filing Viking Therapeutics (VKTX) Tops Q4 EPS by 3c March 13, 2019 4:12 PM - StreetInsider Viking Therapeutics Reports Fourth Quarter and Year-End 2018 Financial Results and Provides Corporate Update March 13, 2019 4:05 PM - PR NewsWire Ligand Provides Highlights from Today’s Analyst Day Event March 12, 2019 10:00 AM - BizWire Viking Therapeutics to Report Financial Results for Fourth Quarter and Year-End 2018 on March 13, 2019 March 6, 2019 7:30 AM - PR NewsWire Viking Therapeutics to Participate in Upcoming Investor Conferences and Events February 26, 2019 7:30 AM - PR NewsWire Pre-Open Stock Movers 02/19: (ICPT) (NAVI) (VKTX) (ORBK) Higher; (WIN) (SLCA) (WTW) Lower (more...) February 19, 2019 8:56 AM - StreetInsider Viking Therapeutics (VKTX) Trades Higher Following Positive Results From Intercept Pharma (ICPT) February 19, 2019 7:41 AM - StreetInsider Full Article List